• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射双膦酸盐(BRONJ)治疗患者的颌骨骨坏死:简要更新。

Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update.

机构信息

Valencia University, Valencia, Spain.

出版信息

Oral Oncol. 2009 Jul;45(7):551-4. doi: 10.1016/j.oraloncology.2009.01.002. Epub 2009 Feb 28.

DOI:10.1016/j.oraloncology.2009.01.002
PMID:19251474
Abstract

Bisphosphonate-related osteonecrosis of the jaws (BRONJ) is a severe complication seen most frequently in patients on intravenous bisphosphonates treatment for malignant diseases. High potency bisphosphonates are generally implicated and risk factors also include dental extractions. Prevention is of paramount importance. Management is controversial but there is little evidence basis and the consensus is to be conservative. Recent advances in this area are summarised in this concise review.

摘要

颌骨骨坏死与双膦酸盐相关(BRONJ)是一种严重的并发症,最常发生在接受静脉内双膦酸盐治疗恶性疾病的患者中。通常与高活性双膦酸盐有关,且危险因素还包括拔牙。预防至关重要。治疗存在争议,但证据基础很少,共识是要保守治疗。本文简要综述了这一领域的最新进展。

相似文献

1
Osteonecrosis of the jaws in patients treated with intravenous bisphosphonates (BRONJ): A concise update.静脉注射双膦酸盐(BRONJ)治疗患者的颌骨骨坏死:简要更新。
Oral Oncol. 2009 Jul;45(7):551-4. doi: 10.1016/j.oraloncology.2009.01.002. Epub 2009 Feb 28.
2
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.美国口腔颌面外科医师协会关于双膦酸盐相关颌骨坏死的立场文件——2009年更新版
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):2-12. doi: 10.1016/j.joms.2009.01.009.
3
Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.日本全国范围内双膦酸盐相关颌骨坏死的调查。
J Oral Maxillofac Surg. 2011 Nov;69(11):e364-71. doi: 10.1016/j.joms.2011.03.051. Epub 2011 Jul 23.
4
Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.静脉注射双膦酸盐治疗与双膦酸盐相关的颌骨坏死
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):44-52. doi: 10.1016/j.joms.2008.12.004.
5
American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws.美国口腔颌面外科医师协会关于双膦酸盐相关颌骨坏死的立场文件。
J Oral Maxillofac Surg. 2007 Mar;65(3):369-76. doi: 10.1016/j.joms.2006.11.003.
6
[Bisphosphonates (BP) and osteonecrosis of the jaws; should administration of BP be discontinued at the early phase?].[双膦酸盐(BP)与颌骨骨坏死;BP治疗在早期阶段是否应停药?]
Clin Calcium. 2010 Nov;20(11):1740-3.
7
Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.双膦酸盐相关颌骨坏死:背景及诊断、分期与管理指南
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Oct;102(4):433-41. doi: 10.1016/j.tripleo.2006.06.004. Epub 2006 Jul 31.
8
Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.口服双膦酸盐作为颌骨双膦酸盐相关骨坏死的一个病因:临床发现、风险评估及预防策略。
J Oral Maxillofac Surg. 2009 May;67(5 Suppl):35-43. doi: 10.1016/j.joms.2009.01.003.
9
[Bisphosphonate-related osteonecrosis of the jaw].[双膦酸盐相关颌骨坏死]
Ned Tijdschr Geneeskd. 2011;155:A3077.
10
[Encounter of cancer cells with bone. Present status and problems in occurrence of bisphosphonate-related osteonecrosis of the jaws].[癌细胞与骨的相遇。双膦酸盐相关颌骨坏死发生的现状与问题]
Clin Calcium. 2011 Mar;21(3):420-7.

引用本文的文献

1
Interventions for managing medication-related osteonecrosis of the jaw.干预措施管理与药物相关的颌骨坏死。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD012432. doi: 10.1002/14651858.CD012432.pub3.
2
Regenerative effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) after sequestrectomy of medication-related osteonecrosis of the jaw (MRONJ).重组人骨形态发生蛋白-2/可吸收胶原海绵(rhBMP-2/ACS)在药物相关性颌骨坏死(MRONJ)死骨切除术后的再生作用
J Korean Assoc Oral Maxillofac Surg. 2020 Jun 30;46(3):191-196. doi: 10.5125/jkaoms.2020.46.3.191.
3
Biomarkers to predict the onset of biphosphonate-related osteonecrosis of the jaw: A systematic review.
预测双膦酸盐相关颌骨坏死发病的生物标志物:一项系统评价
Med Oral Patol Oral Cir Bucal. 2019 Jan 1;24(1):e26-e36. doi: 10.4317/medoral.22763.
4
Osteonecrosis of the Jaw Associated with Antiangiogenics in Antiresorptive-Naïve Patient: A Comprehensive Review of the Literature.抗吸收药物初治患者的抗血管生成药物相关性颌骨坏死:文献全面综述。
Biomed Res Int. 2018 Apr 23;2018:8071579. doi: 10.1155/2018/8071579. eCollection 2018.
5
Interventions for managing medication-related osteonecrosis of the jaw.颌骨药物相关性骨坏死的管理干预措施。
Cochrane Database Syst Rev. 2017 Oct 6;10(10):CD012432. doi: 10.1002/14651858.CD012432.pub2.
6
Interrelationship of clinical, radiographic and haematological features in patients under bisphosphonate therapy.双膦酸盐治疗患者临床、影像学和血液学特征的相互关系。
Dentomaxillofac Radiol. 2017 Apr;46(4):20160260. doi: 10.1259/dmfr.20160260. Epub 2017 Feb 17.
7
Medication-related osteonecrosis of the jaw: a preliminary retrospective study of 130 patients with multiple myeloma.药物相关性颌骨坏死:130例多发性骨髓瘤患者的初步回顾性研究
Maxillofac Plast Reconstr Surg. 2017 Jan 5;39(1):1. doi: 10.1186/s40902-016-0099-4. eCollection 2017 Dec.
8
Analysis of different therapeutic protocols for osteonecrosis of the jaw associated with oral and intravenous bisphosphonates.与口服和静脉注射双膦酸盐相关的颌骨坏死的不同治疗方案分析。
Med Oral Patol Oral Cir Bucal. 2017 Jan 1;22(1):e43-e57. doi: 10.4317/medoral.21477.
9
Oral care and the use of bone-targeted agents in patients with metastatic cancers: A practical guide for dental surgeons and oncologists.转移性癌症患者的口腔护理及骨靶向药物的应用:牙科医生和肿瘤学家实用指南
J Bone Oncol. 2013 Jan 1;2(1):38-46. doi: 10.1016/j.jbo.2012.12.001. eCollection 2013 Feb.
10
Prevention of medication-related osteonecrosis of the jaws secondary to tooth extractions. A systematic review.拔牙继发药物相关性颌骨坏死的预防。一项系统评价。
Med Oral Patol Oral Cir Bucal. 2016 Mar 1;21(2):e250-9. doi: 10.4317/medoral.20963.